Pharmabiz15m
Körber certifies eschbach’s Shiftconnector platform for enhanced shopfloor collaboration using PAS-X MES data
Körber certifies eschbach’s Shiftconnector platform for enhanced shopfloor collaboration using PAS-X MES data: Lüneburg, Germany Wednesday, March 19, 2025, 17:00 Hrs [IST] Kö ...
Pharmabiz1h
Virax Biolabs begins enrolling patients in clinical study assessing T cell dysfunction in post-acute infection syndromes
Virax Biolabs begins enrolling patients in clinical study assessing T cell dysfunction in post-acute infection syndromes: London Wednesday, March 19, 2025, 16:00 Hrs [IST] Virax B ...
Pharmabiz1h
AFMS and NIMHANS sign MoU for collaborative research and training mental health and neurosciences
AFMS and NIMHANS sign MoU for collaborative research and training mental health and neurosciences: Our Bureau, Bengaluru Wednesday, March 19, 2025, 15:45 Hrs [IST] National Instit ...
Pharmabiz2h
AiMeD urges govt to prioritize healthcare security through balanced tariff measures for medical devices
AiMeD urges govt to prioritize healthcare security through balanced tariff measures for medical devices: Our Bureau, New Delhi Wednesday, March 19, 2025, 15:15 Hrs [IST] The Assoc ...
Pharmabiz2h
Medit introduces Medit SmartX, a new All-on-X solution
Medit, a global leader in digital dentistry, has launched its latest All-on-X solution, Medit SmartX. This innovative solution empowers implant clinicians to fully leverage the potential of the ...
Pharmabiz2h
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products
Sovereign Pharma achieves EU approval for aseptic and terminally sterilized injectable products: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:45 Hrs [IST] Sovereign Pharma, ...
Pharmabiz2h
Irish medtech leader Aerogen opens India headquarters in the National Capital Territory of Delhi
Irish medtech leader Aerogen opens India headquarters in the National Capital Territory of Delhi: Our Bureau, Bengaluru Wednesday, March 19, 2025, 14:30 Hrs [IST] Aerogen, the Ire ...
Pharmabiz3h
US FDA grants Fast Track designation to Johnson & Johnson’s nipocalimab to treat adult patients with moderate-to-severe Sjögren’s disease
Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...
Pharmabiz4h
Cellogen Therapeutics gets DCGI nod to develop indigenous Bi-Specific 3rd Generation CAR T cells for cancer
Our Bureau, Bengaluru Wednesday, March 19, 2025, 13:15 Hrs [IST] ...
Pharmabiz4h
Oncorena receives US FDA approval to initiate studies in US
Oncorena, a Swedish pharma company, announced that the US FDA has approved the company’s IND application to initiate the phase I/II study Oncorella-1: A phase 1/2, open label, single arm study on ...
Pharmabiz4h
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset
Shilpa Biologicals inks pact with mAbTree Biologics for a novel immuno-oncology asset: Our Bureau, Bengaluru Wednesday, March ...
Pharmabiz4h
USV launches empagliflozin and its combinations for diabetes care in India
USV launches empagliflozin and its combinations for diabetes care in India: Our Bureau, Bengaluru Wednesday, March 19, 2025, 12:40 Hrs [IST] USV, an Indian multinational healthcar ...